Affordability programs are accelerating rapidly as pharma manufacturers double down on patient support. But in all the investments and efforts that go toward building these programs, are drug developers losing ground when it comes to sustaining them?

Maybe so, but real-time data can help. Advanced analytics are helping to optimize program design, preempt financial waste, and keep affordability programs the evergreen resources they were meant to be.

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post How Small Banks Can Compete with Big Tech
Next post Legal Dive Outlook for 2023